|
gptkbp:instanceOf
|
chemical compound
|
|
gptkbp:chemicalFormula
|
sulfonamide
C20H22N4O4S
|
|
gptkbp:clinicalTrials
|
Phase II
|
|
gptkbp:collaborations
|
gptkb:ABC_Pharmaceuticals
|
|
gptkbp:compatibleWith
|
high
|
|
gptkbp:composedOf
|
chemical synthesis
|
|
gptkbp:developedBy
|
Wiley_Medical
|
|
gptkbp:dissolved
|
soluble in DMSO
slightly soluble in water
|
|
gptkbp:endOfLife
|
4 hours
|
|
gptkbp:future_plans
|
clinical trials
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
WME-770
|
|
gptkbp:isATypeOf
|
123456-78-9
|
|
gptkbp:model
|
xenograft_model
|
|
gptkbp:numberOfStudents
|
renal
|
|
gptkbp:patentStatus
|
patented
|
|
gptkbp:regulatoryCompliance
|
investigational new drug
|
|
gptkbp:releaseYear
|
2010
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:researchInterest
|
gptkb:Journal_of_Cancer_Research_and_Clinical_Oncology
gptkb:Clinical_Cancer_Research
gptkb:Cancer_Research
gptkb:Journal_of_Biological_Chemistry
gptkb:XYZ_University
gptkb:British_Journal_of_Cancer
gptkb:Journal_of_Pharmaceutical_Sciences
gptkb:Journal_of_Clinical_Oncology
gptkb:Journal_of_Cancer_Research
gptkb:Cancer_Epidemiology,_Biomarkers_&_Prevention
Nature Reviews Cancer
Annals of Oncology
Cancer Treatment Reviews
Journal of Medicinal Chemistry
Cancer Letters
Cancer Chemotherapy and Pharmacology
Journal of Cancer Therapy
Oncology Reports
Pharmaceutical_Research
Cancer_Immunology_Research
Molecular_Cancer_Therapeutics
Cancer_Biology_&_Therapy
European_Journal_of_Cancer
Journal_of_Cancer_Research_and_Therapeutics
Trends_in_Cancer_Research
|
|
gptkbp:route
|
oral
|
|
gptkbp:sideEffect
|
fatigue
headache
nausea
|
|
gptkbp:targetAudience
|
gptkb:VEGFR
gptkb:EGFR
|
|
gptkbp:targets
|
specific cancer cells
|
|
gptkbp:triggerType
|
inhibits tumor growth
|
|
gptkbp:usedFor
|
treatment of cancer
|
|
gptkbp:weight
|
402.48 g/mol
|